News & Views | Published:

IMMUNOTHERAPY

Targeting the cancer mutanome of breast cancer

Nature Medicinevolume 24pages703704 (2018) | Download Citation

A metastatic hormone receptor–positive breast cancer, usually resistant to immunotherapy, is successfully treated with tumor-infiltrating lymphocytes enriched for neoantigen reactivity, underscoring the broad potential of this immunotherapeutic approach.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Campbell, B. B. et al. Cell 171, 1042–1056.e1010 (2017).

  2. 2.

    Alvarez, B., Barra, C., Nielsen, M. & Andreatta, M. Proteomics https://doi.org/10.1002/pmic.201700252 (2018).

  3. 3.

    Efremova, M., Finotello, F., Rieder, D. & Trajanoski, Z. Front. Immunol. 8, 1679 (2017).

  4. 4.

    Dudley, M. E. et al. Science 298, 850–854 (2002).

  5. 5.

    Rosenberg, S. A. Nat. Rev. Clin. Oncol. 8, 577–585 (2011).

  6. 6.

    Goodman, A. M. et al. Mol. Cancer Ther. 16, 2598–2608 (2017).

  7. 7.

    Schumacher, T. N. & Hacohen, N. Curr. Opin. Immunol. 41, 98–103 (2016).

  8. 8.

    Zacharakis, N. et al. Nat. Med. https://doi.org/10.1038/s41591-018-0040-8 (2018).

  9. 9.

    Bobisse, S. et al. Nat. Commun. 9, 1092 (2018).

  10. 10.

    Robbins, P. F. et al. Nat. Med. 19, 747–752 (2013).

  11. 11.

    Kreiter, S. et al. Nature 520, 692–696 (2015).

  12. 12.

    Chowell, D. et al. Science 359, 582–587 (2018).

Download references

Acknowledgements

The author thanks all colleagues and scientists who over the years have shared ideas and concepts and have worked diligently to develop cell therapy and vaccination for cancer, bringing it to the forefront of immunotherapy.

Author information

Affiliations

  1. Ontario Institute for Cancer Research, Toronto, Ontario, Canada

    • Laszlo G. Radvanyi

Authors

  1. Search for Laszlo G. Radvanyi in:

Competing interests

The author declares no competing interests.

Corresponding author

Correspondence to Laszlo G. Radvanyi.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/s41591-018-0065-z

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing